200 BERKELEY STREET, BOSTON, MA
Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
Provides Corporate Update and Highlights Expected 2026 Milestones
Amendments to Articles of Incorporation or Bylaws, Other Events
Adicet Bio, Inc. Stockholders Approve Reverse Stock Split Proposal
Reports Third Quarter 2025 Financial Results and Provides Business Updates
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Pipeline Chart, Investor Presentation
News, Underwriting Agreement, Securities Holder Rights or Indentures, Legal Opinion
FY 2025
Q3
Q2
Q1
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
S-8 POS
Correspondence
Submission Upload
Definitive Revised Proxy Statement